Drug correction of endothelial dysfunction in children with chronic pyelonephritis
Journal Title: Здоров`я дитини - Year 2018, Vol 13, Issue 7
Abstract
Background. Timely and sufficient drug correction of endothelial dysfunction in children with chronic pyelonephritis determines the effectiveness of preventing its progression, improves cardiovascular and renal prognosis. The purpose of the study was to examine the effectiveness of various regimens of drug correction for endothelial dysfunction in children with chronic pyelonephritis. Materials and methods. Thirty seven children aged 11–17 years with non-acute chronic pyelonephritis were examined. Thus, the first group of 17 patients received baseline therapy of chronic pyelonephritis, including angiotensin-converting enzyme (ACE) inhibitor enalapril; the second group of 20 patients in addition to standard therapy with ACE inhibitor received the intravenous infusion of L-arginine and then took its oral solution. Results. Patients in the first group had a tendency to increase in the diameter of the brachial artery at rest (2.4 ± 0.1 mm), in the phase of maximal vasodilation (2.9 ± 0.1 mm), without a significant difference from the state before the treatment. An increment of the brachial artery diameter after the treatment had significantly increased in comparison with the level before the treatment (12.00 ± 0.39 mm). Moreover, the reduction of linear blood flow velocity at rest was not statistically significant (146.90 ± 1.13 cm/s). In the second group, there was a significant increase in the brachial artery diameter at rest (2.80 ± 0.13 mm) and in the phase of maximal vasodilation (3.40 ± 0.14 mm) as compared to the baseline. Meanwhile, an increase in the brachial artery diameter after treatment was not significantly different from the physiological norm (17.20 ± 0.41 mm). The linear blood flow velocity at rest was close to the value in the control group, with no significant difference (141.20 ± 1.16 cm/s). In general, the manifestations of endothelial dysfunction decreased by 26.9 and 47.8 % in the first and second groups, respectively. Conclusions. In patients with chronic pyelonephritis without manifestations of chronic renal failure, monotherapy with ACE inhibitor enalapril is effective. In patients with manifestations of chronic renal failure degree I–II, it is advisable to use combined therapy with L-arginine.
Authors and Affiliations
L. I. Vakulenko
Keywords
Related Articles
- EP ID EP423720
- DOI 10.22141/2224-0551.13.7.2018.148919
- Views 73
- Downloads 0
The Value of Glutathione-S-Transferase Gene Polymorphisms (GSTM1, GSTT1) in Various Inflammatory Phenotypes of Bronchial Asthma in Children
The aim of research: to study the peculiarities of a heterogeneous airway inflammation in children with bronchial asthma (BA) under the deletion polymorphism of GSTM1 and GSTT1 genes. Materials and Methods. We have exami...
Adverse Events Following Immunization
.
Surgical Treatment and Rehabilitation of Children with Pathology of the Pancreas
Relevance. Surgical treatment of pancreas pathology in children is quite difficult in pediatric surgery. The diversity of pathology in congenital anomalies in the glands structure, complications, ectopic tissue of pancr...
Microelement provision state in patients with paroxysmal autonomic failure on the background of thyroid pathology
Background. The study of changes in the micronutrient content and its correlation with physical state in patients with paroxysmal autonomic failure (PAF) on the background of thyroid pathology is relevant. Materials and...
Development of the immune response in pneumonia due to Staphylococcus aureus (part 6)
The article on the basis of literature data demonstrates the role of cellular reactions in the development of the immune response in pneumonia caused by Staphylococcus aureus. Тhe mechanisms of interaction of Staphylococ...